全文获取类型
收费全文 | 32670篇 |
免费 | 2138篇 |
国内免费 | 99篇 |
专业分类
耳鼻咽喉 | 490篇 |
儿科学 | 851篇 |
妇产科学 | 377篇 |
基础医学 | 4099篇 |
口腔科学 | 491篇 |
临床医学 | 3282篇 |
内科学 | 7573篇 |
皮肤病学 | 229篇 |
神经病学 | 3249篇 |
特种医学 | 1580篇 |
外科学 | 5349篇 |
综合类 | 294篇 |
一般理论 | 72篇 |
预防医学 | 2239篇 |
眼科学 | 420篇 |
药学 | 1970篇 |
中国医学 | 23篇 |
肿瘤学 | 2319篇 |
出版年
2023年 | 150篇 |
2022年 | 236篇 |
2021年 | 727篇 |
2020年 | 409篇 |
2019年 | 714篇 |
2018年 | 868篇 |
2017年 | 599篇 |
2016年 | 681篇 |
2015年 | 786篇 |
2014年 | 1143篇 |
2013年 | 1445篇 |
2012年 | 2354篇 |
2011年 | 2398篇 |
2010年 | 1413篇 |
2009年 | 1167篇 |
2008年 | 2167篇 |
2007年 | 2249篇 |
2006年 | 2162篇 |
2005年 | 2161篇 |
2004年 | 1935篇 |
2003年 | 1851篇 |
2002年 | 1789篇 |
2001年 | 315篇 |
2000年 | 244篇 |
1999年 | 318篇 |
1998年 | 406篇 |
1997年 | 352篇 |
1996年 | 288篇 |
1995年 | 284篇 |
1994年 | 250篇 |
1993年 | 236篇 |
1992年 | 190篇 |
1991年 | 200篇 |
1990年 | 177篇 |
1989年 | 177篇 |
1988年 | 165篇 |
1987年 | 153篇 |
1986年 | 145篇 |
1985年 | 151篇 |
1984年 | 168篇 |
1983年 | 143篇 |
1982年 | 155篇 |
1981年 | 141篇 |
1980年 | 117篇 |
1979年 | 70篇 |
1978年 | 79篇 |
1977年 | 70篇 |
1976年 | 53篇 |
1975年 | 50篇 |
1974年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
121.
The objective of this study was to test the impact of entacapone (ENT) addition to levodopa with a decarboxylase inhibitor (LD) in full-time-employed patients with Parkinson's disease (PD), focusing on retirement rates, medical absenteeism, self-perception of disability, as well as motor assessments of parkinsonism, motor fluctuations, and dyskinesias. Thirty full-time-employed PD patients (disease onset before age 60 years) and on optimized monotherapy with LD exhibiting minor motor fluctuations or dyskinesias were entered into a 2-year randomized double-blind placebo-controlled study of ENT adjunctive therapy. The outcome measures were the number of full-time-employed patients at study end, cumulative days of medical absenteeism, patient-completed disability assessments, diary records, and the Unified Parkinson's Disease Rating Scale-based measures of motor fluctuations and dyskinesias. LD + ENT treatment was associated with a lower retirement rate (2 [17%] of 12 vs. 6 [50%] of 12; P = 0.12), lower absenteeism rate (21.5 vs. 43.5 days; P < 0.0001), improved self-perception of disability progression over 2 years (change score 1.0 vs. 4.5; P < 0.0001), and lower scores for both motor fluctuations and dyskinesia assessments compared to LD monotherapy. In this pilot study, LD with ENT adjunctive therapy positively influenced employment rate over 2 years; this effect was associated with reduced motor complications and patient perceptions of stabilized disability. 相似文献
122.
123.
Pankaj K Singhal Gregory Spiegel Deborah Driscoll Kunle Odunsi Shashikant Lele Kerry J Rodabaugh 《International journal of gynecological pathology》2005,24(1):62-66
This study was designed to investigate the expression of cyclooxygenase (COX)-2 in ovarian serous tumors (benign, borderline tumors, and carcinomas) and primary peritoneal serous carcinomas. Cases diagnosed between 1995 and 2001 were reviewed; 47 benign tumors, 6 borderline tumors, and 39 carcinomas were examined, as well as 12 normal ovaries that served as controls. Blocks were stained with anti COX-2 polyclonal antibody and staining was graded qualitatively. The staining intensity was assessed as weak (score of 1), moderate (score of 2), or strong (score of 3). Normal ovarian and tubal epithelium, inclusion cysts, benign serous tumors, and borderline tumors had a uniform score 3 staining pattern. Serous ovarian carcinomas had variable staining scores, tending to correlate with the level of tumor differentiation. Well-differentiated carcinomas had more intense COX-2 staining than poorly differentiated carcinomas, which had only weak COX-2 staining. The degree of COX-2 staining was not significantly related to overall survival. In conclusion, COX-2 expression is present in serous tumors, including benign tumors, borderline tumors, and carcinomas. Similar to the findings in other neoplasms, COX-2 expression is strongest in well-differentiated tumors and is much less evident in those that are poorly differentiated. The clinical utility of these findings is related to the potential role of nonsteroidal anti-inflammatory drugs, which are COX-2 inhibitors, in treating and/or preventing some forms of ovarian carcinoma. 相似文献
124.
Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis. 总被引:6,自引:0,他引:6
Mohammed A Qadeer John J Vargo Farah Khandwala Rocio Lopez Gregory Zuccaro 《Clinical gastroenterology and hepatology》2005,3(11):1049-1056
BACKGROUND & AIMS: Even though propofol has better recovery profile than traditional agents, its use is limited because of the perception of increased complication rates. Because an adequately powered trial comparing risk of propofol with traditional agents is lacking, we performed a meta-analysis of the current literature. METHODS: We searched Medline (1966-October 2004), EMBASE (1980-October 2004), and Cochrane controlled trials registry. The following 4 cardiopulmonary complications were assessed: hypoxia, hypotension, arrhythmias, and apnea. Procedures were divided into 3 groups: esophagogastroduodenoscopy group, colonoscopy group, and endoscopic retrograde cholangiopancreatography/endoscopic ultrasonography group. Pooled odds ratios for complications were calculated for all the procedures combined and then separately for the 3 groups. Random effects models were used for 2-proportion comparisons. RESULTS: Of the 90 citations identified, 12 original studies qualified for this meta-analysis and included 1161 patients. Of these, 634 received propofol, and 527 received midazolam, meperidine, and/or fentanyl. Most of the included studies were randomized trials of moderate quality and nonsignificant heterogeneity (Cochran Q = 4.81, P = .90). Compared with traditional sedative agents, the pooled odds ratio with the use of propofol for developing hypoxia or hypotension for all the procedures combined was 0.74 (95% confidence interval [CI], 0.44-1.24); for EGD, 0.85 (95% CI, 0.33-2.17); for colonoscopy, 0.4 (95% CI, 0.2-0.79); and for ERCP/EUS, 1.07 (95% CI, 0.38-3.01). CONCLUSIONS: Propofol sedation during colonoscopy appears to have lower odds of cardiopulmonary complications compared with traditional agents, but for other procedures, the risk of complications is similar. 相似文献
125.
Gregory M. Marcus MD Yanfei Yang MD Paul D. Varosy MD Karen Ordovas MD Zian H. Tseng MD Nitish Badhwar MBBS Byron K. Lee MD Randall J. Lee MD Melvin M. Scheinman MD Jeffrey E. Olgin MD 《Heart rhythm》2007,4(2):138-144
BACKGROUND: Regional differences in fibrosis, particularly related to the posterior wall and septum, may be important in atrial fibrillation (AF). Using electroanatomic mapping, voltage can be used as a measure of fibrosis. OBJECTIVES: The purpose of this study was to determine if patients with AF have disproportionately lower voltage in the septal and posterior walls of the left atrium. METHODS: Sinus rhythm left atrial electroanatomic maps were used in serial patients presenting for left atrial ablation of AF (8-mm tip). Patients undergoing left atrial mapping for focal atrial tachycardia (AT) were used as a comparison group (4-mm tip). Animal experiments were performed to assess the influence of ablation catheter tip size on voltage amplitude. RESULTS: The posterior and septal walls exhibited the lowest voltages in both groups. Compared with the anterior wall, there was a 3.78-fold greater odds of finding a low-voltage point (<0.5 mV) in the septum (P <.001) and a 3.37-fold greater odds of finding a low-voltage point in the posterior wall (P <.001) in the AF patients; the proportion of low-voltage points by region were not significantly different in the AT group. In the animal model, the mean voltage obtained from an 8-mm ablation catheter was significantly higher (0.30 +/- 0.17 mV) than that obtained from the same points using a 4-mm catheter (0.22 +/- 0.17, P = .05). CONCLUSION: Regional differences in voltage are present in patients with atrial arrhythmias, with AF patients exhibiting significantly more low-voltage areas in the septum and posterior walls. 相似文献
126.
The Chinese version of Scale for Suicide Ideation (SSI; Beck, Kovacs, & Weissman, 1979) was examined with high school students (n = 292) in rural China. Results indicated that the SSI had high internal reliability and high item-total correlations. The SSI was highly correlated with measures of trait anxiety, hopelessness, and favorable attitude towards suicide. These findings indicated that the Chinese version of the SSI has excellent psychometric properties for measuring suicidal ideation in Chinese populations. 相似文献
127.
David M. Dickinson Dawn M. Dykstra Gregory N. Levine Shiqian Li James C. Welch Randall L. Webb 《American journal of transplantation》2005,5(4P2):850-861
The process of collecting and analyzing transplant data is complex. Familiarity with how these data are collected is crucial to a thorough understanding of the information. This article focuses on available OPTN-SRTR data and the continuing evolution of data collection mechanisms; how that data collection system is improving the data quality and reducing the data collection burden; how additional ascertainment of outcomes both completes and validates existing data; and caveats that remain for researchers. This year's article focuses further on research considerations related to cohort choice, timing of data submission, and potential biases in follow-up data. Ongoing improvements in data collection timeliness and scope are covered. The impact of extra ascertainment of outcomes, particularly for post-transplant kidney graft failure from Medicare data, are also examined. A section on graft failure reporting among different sources traces the steps by which the SRTR reconciles different data sources in its analyses. It is important that those reading and conducting transplant research understand the origin, structure, and scope of the available data. All of these issues should be carefully considered when choosing cohorts and data sources for analysis. 相似文献
128.
129.
130.
Growth hormone effects on hypertrophic scar formation: a randomized controlled trial of 62 burned children 总被引:3,自引:0,他引:3
Gisele V. de Oliveira MD ; Arthur P. Sanford MD ; Kevin D. Murphy MD ; Hermes M. de Oliveira MD ; Judy P. Wilkins RGN ; Xiaowu Wu MD ; Hal K. Hawkins MD PhD ; Gregory Kitten PhD ; David L. Chinkes PhD ; Robert E. Barrow PhD ; David N. Herndon MD 《Wound repair and regeneration》2004,12(4):404-411
The hypercatabolism after massive pediatric burns has been effectively treated with recombinant human growth hormone, an anabolic agent that stimulates protein synthesis and abrogates growth arrest. While experimental studies have shown increased potential for fibrosis induced by growth hormone therapy, adverse effects on human scars have not been investigated. Our aim was to evaluate hypertrophic scar formation in 62 patients randomized to receive injections of 0.05 mg/kg/day of recombinant human growth hormone or placebo, from discharge until 1 year after burn. Scar scales were used to evaluate scar-severity at discharge, 6, 9, 12, and 18-24 months after burn, by three observers blinded to treatment. Computer-assisted planimetry allowed quantification of percentage of hypertrophic scar formation. Types I and III collagens were localized and quantified in scars and normal skin of patients from both groups, using immunohistochemistry with confocal laser microscopy analysis. Insulin-like growth factor-1 blood levels helped assess compliance. Statistical analysis showed that scar hypertrophy significantly increased from 6 to 12 months after injury in both groups, while decreasing at 18-24 months postburn. Types I and III collagens were statistically increased in the reticular layer of scars from both groups when compared to paired normal skin. Insulin-like growth factor-1 was significantly increased in the recombinant human growth factor-treated group. No differences were seen when recombinant human growth factor and control groups were compared using the scar scales, planimetry, or immunohistochemistry. We concluded that recombinant human growth hormone therapy did not adversely affect scar formation and should not contraindicate the administration of recombinant human growth hormone as a therapeutic approach to severely burned children. 相似文献